Earth Science Tech (ETST) Notes Payables (2012 - 2025)

Earth Science Tech's (ETST) quarterly Notes Payables came in at $179488.0 in Q1 2025, up 163.76% on a QoQ basis from $68050.0 in Q4 2023.

Earth Science Tech (ETST) Notes Payables (2012 - 2025) Analysis & Trends

Earth Science Tech (ETST) has 11 years of Notes Payables data on file, last reported at $179488.0 in Q1 2025.

Quarterly Notes Payables changed N/A year-over-year to $179488.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $179488.0 (changed N/A YoY) and the FY2025 annual result came in at $179488.0, changed N/A from the prior year.
Notes Payables climbed to $179488.0 in Q1 2025, from $68050.0 in the prior quarter.
In the past five years, Notes Payables ranged from a high of $179488.0 in Q1 2025 to a low of $3582.0 in Q2 2023.
A 4-year average of $77521.9 and a median of $68050.0 in 2023 frame the typical range for Notes Payables.
Annual changes were most pronounced in 2022 — Notes Payables jumped 243.19% — and 2023, when it tumbled 96.57%.
Tracing ETST's Notes Payables over 4 years: stood at $105669.0 in 2021, then retreated by 2.57% to $102956.0 in 2022, then slumped by 33.9% to $68050.0 in 2023, then jumped by 163.76% to $179488.0 in 2025.
The last three Notes Payables figures came in at $179488.0 (Q1 2025), $68050.0 (Q4 2023), and $44256.0 (Q3 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Earth Science Tech	31.63 Mn	28.84 Mn	6.28 Mn

Download Data